Australasian Gastro-Intestinal Trials Group (AGITG) STOPNET: A randomized study of cessation of somatostatin analogues (SSA) after peptide receptor radionuclide therapy (PRRT) in mid, hind-gut, and pancreatic neuroendocrine tumours.

Authors: Matthew E. Burge, David Wyld, David A. Pattison, Sandra Bahamad, Sarah J. Hayes, Julia A. Kuszewski, Lorraine A. Chantrill, Timothy Jay Price, Hui-Li Wong, David Chan, Piyush Grover, Michael Michael, Derrick Siu, Christine Bishop, Daniel Barker, Rachel Anne Goodwin, Christopher J. O'Callaghan, Jonathan M. Loree, W. John Mak

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps4224

Source: Full article

---

Abstract

TPS4224